Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Charles Turck, PharmD, BCPS, BCCCP
Anthony Stein, MD
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Urvi A. Shah, MD, MS
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Alleviating Anemia in Myelofibrosis: New Therapeutic Avenues
Prithviraj Bose, MD
Managing Anemia in Myelofibrosis: A Multidisciplinary Approach
Brian P. McDonough, MD, FAAFP
Douglas Tremblay, MD
Marina Kremyanskaya, MD
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
John Mascarenhas, MD
Lucia Masarova, MD
Exercise in Multiple Myeloma: Balancing Benefits and Safety
Jens Hillengass, MD, PhD
Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
Diagnosing Castleman Disease: Key Considerations
Mateo Bustamante
Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
Joshua Brandstadter, MD, PhD, MSc
CAR T-Cell Therapy for R/R Mantle Cell Lymphoma: Key Considerations
Chenyu Lin, MD
Examining Key Data on CAR T-Cell Therapy for Relapsed/Refractory MCL
Jennifer Caudle, DO
Matthew Matasar, MD
Enhancing Outcomes in Relapsed/Refractory B-ALL with CAR T-Cell Therapy
Gates B. Colbert, MD
Ryan Cassaday, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.